Literature DB >> 7297345

A fluorescence polarization flow cytometer.

J P Keene, B W Hodgson.   

Abstract

The effect of mitogens on the degree of polarization of the fluorescence from viable human lymphocytes, labeled with fluorescein, have been reported to be different in cells from subjects with malignant disease as compared with those from healthy donors. This has potential applications in the field of clinical diagnosis and a flow cytometer could be the instrument of choice for this purpose. We believe that such an instrument should be simple and easy to use and a flow cytometer was assembled with this in mind and with the object of gaining experience which would provide the basis for a future finalized design. The instrument is suitable for use in other biologic applications where polarization is of interest and also as a general purpose flow cytometer. Its main features, its characteristics and preliminary performance report are presented here.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7297345     DOI: 10.1002/cyto.990010205

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  4 in total

1.  The limitations of nonlinear fluorescence effect in super resolution saturated structured illumination microscopy system.

Authors:  Aviram Gur; Zeev Zalevsky; Vicente Micó; Javier García; Dror Fixler
Journal:  J Fluoresc       Date:  2010-12-30       Impact factor: 2.217

2.  Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures.

Authors:  A T McGown; T H Ward; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Effects of irradiation on the interaction of fluorescent probes with lymphocytes.

Authors:  J C Standefer; R E Anderson; M Wilder; J Martin
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

Review 4.  Fluorescence anisotropy imaging in drug discovery.

Authors:  Claudio Vinegoni; Paolo Fumene Feruglio; Ignacy Gryczynski; Ralph Mazitschek; Ralph Weissleder
Journal:  Adv Drug Deliv Rev       Date:  2018-02-02       Impact factor: 15.470

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.